- Bausch is seeking cash compensation to be determined at trial and court orders that Harrow “immediately cease all distribution and sale” of allegedly infringing product, recall all such products from marketplace and blocking further unauthorized use of inventions, according to
complaint filed Friday in federal court in Trenton, New Jersey - Complaint targets Harrow’s Epinastine Brimonidine PF product
- Eye Therapies owns patents and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.